Second Primary Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancers after Breast Cancer Diagnosis: Korea Central Cancer Registry
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose A prior history of breast cancer is a risk factor for the subsequent development of primary peritoneal, epithelial ovarian, and fallopian tubal (POFT) cancers. This study aimed to estimate the incidence of secondary POFT malignancy in breast cancer patients and the clinical outcomes of primary and secondary POFT cancer.Materials and Methods We searched the Korea Central Cancer Registry to find patients with primary and secondary POFT cancer who had breast cancer in 1999-2017. The incidence rate and standardized incidence ratio were calculated. Additionally, we compared the overall survival of patients with primary and secondary POFT cancer.Results Based on the age-standardized rate, the incidence of second primary POFT cancer after breast cancer was 0.0763 per 100,000 women, which increased in Korea between 1999 and 2017. Among the 30,366 POFT cancer patients, 25,721 were primary POFT cancer only, and 493 had secondary POFT cancer after a breast cancer diagnosis. Second primary POFT cancer patients were older at the time of diagnosis (55 vs. 53, p < 0.001) and had a larger proportion of serous histology (68.4% vs. 51.2%, p < 0.001) than patients with primary POFT. There were no differences between the two groups in tumor stage at diagnosis. The 5-year overall survival rates were 60.2% and 56.3% for primary and secondary POFT cancer, respectively (p=0.216).Conclusion The incidence of second primary POFT cancer after breast cancer increased in Korea between 1999 and 2017. Besides, second primary POFT cancer patients were diagnosed at older ages and had more serous histology.
Abstract
Purpose A prior history of breast cancer is a risk factor for the subsequent development of primary peritoneal, epithelial ovarian, and fallopian tubal (POFT) cancers. This study aimed to estimate the incidence of secondary POFT malignancy in breast cancer patients and the clinical outcomes of primary and secondary POFT cancer.Materials and Methods We searched the Korea Central Cancer Registry to find patients with primary and secondary POFT cancer who had breast cancer in 1999-2017. The incidence rate and standardized incidence ratio were calculated. Additionally, we compared the overall survival of patients with primary and secondary POFT cancer.Results Based on the age-standardized rate, the incidence of second primary POFT cancer after breast cancer was 0.0763 per 100,000 women, which increased in Korea between 1999 and 2017. Among the 30,366 POFT cancer patients, 25,721 were primary POFT cancer only, and 493 had secondary POFT cancer after a breast cancer diagnosis. Second primary POFT cancer patients were older at the time of diagnosis (55 vs. 53, p < 0.001) and had a larger proportion of serous histology (68.4% vs. 51.2%, p < 0.001) than patients with primary POFT. There were no differences between the two groups in tumor stage at diagnosis. The 5-year overall survival rates were 60.2% and 56.3% for primary and secondary POFT cancer, respectively (p=0.216).Conclusion The incidence of second primary POFT cancer after breast cancer increased in Korea between 1999 and 2017. Besides, second primary POFT cancer patients were diagnosed at older ages and had more serous histology.
참고문헌 (23)
- Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 68, pp.394~424 (2018)
- 강상율, "Breast Cancer Statistics in Korea in 2017: Data from a Breast Cancer Registry", Journal of Breast Cancer, 23(2), pp.115~128 (2020), 한국유방암학회[DOI]
- Metcalfe KA, "The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers", Gynecol Oncol, 96, pp.222~226 (2005)
- Prior P, "Multiple primary cancers of the breast and ovary", Br J Cancer, 44, pp.628~636 (1981)
- 임명철, "Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999–2015", Journal of Gynecologic Oncology, 30(1), pp.1~8 (2019), 대한부인종양학회[DOI]
- Lim MC, "Second primary cancer after primary peritoneal, epithelial ovarian, and fallopian tubal cancer : a retrospective study", BMC Cancer, 18, pp.800~ (2018)
- 홍세리, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017", Cancer Research and Treatment, 52(2), pp.335~350 (2020), 대한암학회
- Fritz A, "International classification of diseases for oncology (ICD-O)" (2013), World Health Organization
- Young JL Jr, "SEER summary staging manual 2000: codes and coding instructions" (2001), National Cancer Institute
- Mellemkjaer L, "Risk of second cancer among women with breast cancer", Int J Cancer, 118, pp.2285~2292 (2006)
- Berkowitz Z, "Characteristics and survival associated with ovarian cancer diagnosed as first cancer and ovarian cancer diagnosed subsequent to a previous cancer", Cancer Epidemiol, 35, pp.112~119 (2011)
- Schonfeld SJ, "Declining second primary ovarian cancer after first primary breast cancer", J Clin Oncol, 31, pp.738~743 (2013)
- Schaapveld M, "Risk of new primary nonbreast cancers after breast cancer treatment : a Dutch population-based study", J Clin Oncol, 26, pp.1239~1246 (2008)
- 신원교, "Incidence trends for epithelial peritoneal, ovarian, and fallopian tube cancer during 1999–2016: a retrospective study based on the Korean National Cancer Incidence Database", Journal of Gynecologic Oncology, 31(4), pp.1~9 (2020), 대한부인종양학회[DOI]
- Bolton KL, "Association between BRCA1 and BRCA2mutations and survival in women with invasive epithelial ovarian cancer", JAMA, 307, pp.382~390 (2012)
- Zhang S, "Frequencies of BRCA1 and BRCA2 mutations among 1, 342unselected patients with invasive ovarian cancer", Gynecol Oncol, 121, pp.353~357 (2011)
- Pal T, "BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases", Cancer, 104, pp.2807~2816 (2005)
- Choi DH, "Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients", J Clin Oncol, 22, pp.1638~1645 (2004)
- Pennington KP, "Hereditary ovarian cancer : beyond the usual suspects", Gynecol Oncol, 124, pp.347~353 (2012)
- Lakhani SR, "Pathology of ovarian cancers in BRCA1 and BRCA2 carriers", Clin Cancer Res, 10, pp.2473~2481 (2004)
- Kauff ND, "Risk of ovarian cancer in BRCA1 and BRCA2mutation-negative hereditary breast cancer families", J Natl Cancer Inst, 97, pp.1382~1384 (2005)
- Son BH, "Changing patterns in the clinical characteristics of Korean patients with breast cancer during the last 15 years", Arch Surg, 141, pp.155~160 (2006)
- Hall HI, "Second primary ovarian cancer among women diagnosed previously with cancer", Cancer Epidemiol Biomarkers Prev, 10, pp.995~999 (2001)